Results 51 to 60 of about 16,888 (302)

Impacto de un centro terciario de ictus en la atención de pacientes con ictus isquémico agudo por disección de arterias cervicales

open access: yesNeurología, 2015
Resumen: Introducción: La disección de arterias cervicales (DAC) es la causa del 2-3% de ictus isquémicos y del 10-25% en pacientes jóvenes. Nuestro objetivo es evaluar si la implementación de un centro terciario de ictus (CTI) facilita el diagnóstico y
M. Almendrote   +12 more
doaj   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Sociocultural study on the self-perception of stroke and an analysis of doctor-patient communication

open access: yesNeurología (English Edition), 2011
Background: Stroke was historically attributed to magical and religious conceptions. We analyse the self-perception of stroke in stroke patients, the knowledge of vascular risk factors (VRF), and doctor-patient communication efficacy from an ...
O. Díez-Ascaso   +3 more
doaj   +1 more source

Incidencia de infección respiratoria asociada a disfagia en pacientes con ictus, tratados en la unidad de ictus del HUCV [PDF]

open access: yes, 2022
Las infecciones respiratorias (IR) son una de las complicaciones más frecuentes tras el ictus. Están asociadas a la presencia de disfagia como consecuencia de la alteración funcional producida por el ictus.
Gómez González, Esther
core  

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Actualización do Plan de asistencia ao ICTUS (Código ICTUS)

open access: yes, 2023
[GLG] Actualízase a asistencia ao ICTUS en Galicia consonte ás novas evidencias científicas que xurdiron nestes anos (dende o ano 2016)[SPA] Se actualiza la asistencia al ICTUS en Galicia conforme a las nuevas evidencias científicas que surgieron en ...
Vázquez Mourelle, Raquel
core   +1 more source

Estudio descriptivo de los stroke mimics después de un estudio neurovascular completo

open access: yesNeurología, 2019
Resumen: Introducción: Un porcentaje de casos diagnosticados inicialmente como infartos isquémicos son de causa no cerebrovascular o stroke mimics (SM). Los datos publicados al respecto son heterogéneos y, generalmente, con cohortes pequeñas.
C. Avellaneda-Gómez   +10 more
doaj   +1 more source

Ictus: Prevención secundaria [PDF]

open access: yes
El ictus es una enfermedad cardiovascular sobre la que se puede realizar una prevención secundaria centrada en reducir en un 80% el riesgo de sufrir un nuevo ictus.
Blasco-Abadía, Julia   +8 more
core   +1 more source

White Matter Microstructural Abnormalities in Neonatal Onset Genetic Epilepsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recent evidence indicates that epilepsy is associated with abnormal white matter. If seizures alter white matter, then the impact upon network function, epileptogenesis, and cognition could be pronounced in neonates undergoing rapid developmental myelination. Neonates with epilepsy due to nonstructural genetic causes provide a unique
Amanda G. Sandoval Karamian   +8 more
wiley   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy